for a Healthier Future

Together we pioneer innovative treatments that address the root causes of vascular conditions, and much more, offering precise and effective solutions for maintaining and restoring vascular health, and overall well being. We are committed to advancing regenerative medicine.

An illustration depicting healthy blood vessels branching out, symbolizing the preventative and restorative effects of the Two-Phase FGF Method on vascular health. The image should convey a sense of scientific advancement and hope.

and Repair Vascular Diseases

The Two-Phase FGF Method is a groundbreaking therapy developed by VivoVac to prevent and repair vascular diseases. This innovative treatment addresses the underlying causes of vascular conditions, providing a precise solution for maintaining vascular health.

Prevention First

The Two-Phase FGF Method is a ground-breaking therapy specifically developed to aim at prevention and repair of vascular diseases. This innovative promise treatments that address the underlying causes of vascular conditions, providing a precise and effective solution for maintaining and restoring vascular health. As an essential element of Regen Factor’s intellectual property portfolio, this patent application signifies a major leap forward in regenerative medicine.

A microscopic image of a healthy coronary artery, showcasing smooth muscle cells and clear blood flow, symbolizing the potential for treating cardiovascular diseases with VivoVac's technology.
Cardiovascular Disease Solutions
Regen Factor offers innovative solutions for coronary artery disease, heart attack, and heart failure, promoting vascular regeneration and improved cardiac function.
A detailed brain scan highlighting areas affected by ischemic stroke, with an overlay showing potential recovery through enhanced vascularization using VivoVac's regenerative therapy.
Cerebrovascular Disease Treatment
Targeting ischemic and hemorrhagic strokes, Regen Factor's technology aims to restore blood flow and neuronal function, mitigating the devastating effects of cerebrovascular conditions.
An artistic representation of neurons affected by vascular dementia, contrasted with healthy neurons regenerated through VivoVac's therapeutic intervention, emphasizing cognitive preservation.
Neurodegenerative Disease Intervention
Regen Factor's approach to vascular dementia and Alzheimer's focuses on improving cerebral blood flow and neuronal health, potentially slowing down or reversing cognitive decline.
Chronic Vascular Disorder Management
Addressing venous insufficiency and diabetic complications, Regen Factor promotes vascular repair and regeneration, offering hope for patients with chronic vascular disorders.

Revolutionizing Regenerative Medicine with AI

ReGen Factor Pty Ltd and VivoVac Pty Ltd, in alliance with LucidAI and GreyCorp AI, are pioneering a new era in regenerative medicine. This collaboration integrates biotech and AI to accelerate the development and validation of innovative therapies. A key achievement is the Two-Phase Vascular Patent, owned globally by ReGen Factor. This therapy prevents and repairs vascular damage using a dual-stage fibroblast growth factor approach.
Supported by advanced AI, the team conducted over 100 million Monte Carlo simulations, demonstrating up to an 85% reduction in vascular events and a 75% functional recovery. LucidAI and GreyCorp AI enable precise modeling, speeding up R&D and minimizing risk. Investors benefit from strong IP, global rights, and a scalable therapy targeting multi-billion-dollar cardiovascular, stroke, and neurodegenerative markets. This marks a breakthrough in AI-driven regenerative health innovation with unmatched commercial potential.
Our Portfolio
Explore our groundbreaking projects that aim to revolutionize healthcare and improve patient outcomes through advanced therapies.
Cancer Prevention
  • Focus: Innovative biological approaches
  • Goal: Prevent cancer
  • Date: March 2025
Learn More
Our Cancer Prevention Research project focuses on developing therapies aimed at preventing cancer through innovative biological approaches. This initiative is crucial for enhancing early detection and treatment options for patients.

Our Research in Regenerative Medicine

VivoVac is at the forefront of biotech innovation, combining cutting-edge AI and biotech to develop groundbreaking therapies. Our collaborations with industry leaders like ReGen Factor, LucidAI, and GreyCorp AI enable us to accelerate discovery and validation processes, aiming to revolutionize health and longevity.

A team of scientists and AI specialists working together in a state-of-the-art laboratory, symbolizing innovation and collaboration in biotech and AI.

Help Us Unlock a , Longer Life for All

At VivoVac, we’re pioneering a future where extending your lifespan doesn’t come at the expense of your happiness. Our cutting-edge research in regenerative medicine focuses on enhancing both your physical health and overall well-being. Discover how our innovative therapies can help you live a more vibrant, fulfilling life, for longer.
By signing up, you agree to our Privacy Policy and Terms and Conditions.

Expression of Interest

Please fill out the form below to express your interest in our innovative solutions in longevity and regenerative medicine.
Submit
Cancel
A professional image of a laboratory setting showcasing biotechnology research, symbolizing innovation in longevity and regenerative medicine.